TEVA PHARMACEUTICAL-SP ADR (TEVA)
US8816242098 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -615.00M | -2.41B | 456.00M | -4.10B | -1.00B | |||
| Depreciation Amortization | 1.15B | 1.31B | 1.33B | 1.56B | 1.72B | |||
| Income Taxes - Deferred | -317.00M | -1.06B | -120.00M | -696.00M | -985.00M | |||
| Change In Working Capital | -72.00M | 1.26B | -1.70B | -2.19B | -896.00M | |||
| Interest Paid | 1.08B | 948.00M | 913.00M | 846.00M | 840.00M | |||
| Taxes Paid | 298.00M | 543.00M | 495.00M | 709.00M | 552.00M | |||
| Other non cash items | 1.22B | 2.49B | 833.00M | 6.64B | 1.91B | |||
| OPERATING CASH FLOW | 1.37B | 1.59B | 798.00M | 1.22B | 748.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -526.00M | -548.00M | -562.00M | -578.00M | -525.00M | |||
| Other Investing Activity | 1.49B | 1.20B | 2.08B | 1.44B | 1.88B | |||
| INVESTING CASH FLOW | 968.00M | 656.00M | 1.52B | 863.00M | 1.35B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.70B | -1.37B | -2.17B | -1.88B | -1.86B | |||
| Stock Issued/Repurchased | N/A | N/A | N/A | N/A | N/A | |||
| Dividend Paid | N/A | N/A | 0.00 | 0.00 | -52.00M | |||
| Other Financing Activity | -212.00M | -118.00M | -6.00M | -5.00M | -11.00M | |||
| FINANCING CASH FLOW | -1.91B | -1.49B | -2.17B | -1.89B | -1.93B | |||
| Exchange Rate Effect | -30.00M | -123.00M | -128.00M | 8.00M | 16.00M | |||
| CHANGE IN CASH | 393.00M | 636.00M | 21.00M | 202.00M | 193.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.37B | 1.59B | 798.00M | 1.22B | 748.00M | |||
| Capital Expenditure | -526.00M | -548.00M | -562.00M | -578.00M | -525.00M | |||
| FREE CASH FLOW | 842.00M | 1.04B | 236.00M | 638.00M | 223.00M | |||
All data in USD